JTEC

JTEC EBIT Margin

The EBIT Margin (Operating Margin) of JTEC (3446.T) as of Oct 19, 2026 is 3.73 %. In the previous year, EBIT Margin (Operating Margin) was 5.91 % — a change of -36.97% (lower).

EBIT Margin

3.73 %

YoY

-36.97%

Last updated:

EBIT Margin (Operating Margin) of JTEC is 2026 3.73 % . EBIT Margin (Operating Margin) of JTEC was 2025 5.91 % . It decreases by -36.97% lower compared to the previous year.

For JTEC, the operating (EBIT) margin of 3.7% is up versus -6.2% a few years ago.

The JTEC EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
5.02 JPY
Jan 1, 2020
0.53 JPY
Jan 1, 2021
-33.33 JPY
Jan 1, 2022
-6.19 JPY
Jan 1, 2023
16.07 JPY
Jan 1, 2024
14.22 JPY
Jan 1, 2025
5.91 JPY
Jan 1, 2026
3.73 JPY
The JTEC EBIT Margin history
YEAREBIT MarginYoY
3.73 %-36.97%
5.91 %-58.43%
14.22 %-11.52%
16.07 %-359.70%
-6.19 %-81.44%
-33.33 %-6,441.27%
0.53 %-89.53%
5.02 %+98.00%
2.54 %-31.77%
3.72 %-68.38%
11.75 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JTEC Stock analysis

What does JTEC do? JTEC Corp, listed on the Tokyo Stock Exchange under ticker 3446.T with ISIN JP3386660009, is a Japanese company operating in the Health Care sector. Headquartered in Ibaraki-shi, Japan, the company employs 64 full-time staff. It completed its initial public offering on February 28, 2018. JTEC Corp develops, designs, manufactures, and sells automation systems, focusing on specialized equipment for scientific and medical applications. The company operates through two business segments. The Optical segment specializes in X-ray nano-collecting mirrors used in synchrotron radiation and X-ray free electron laser facilities, designed for advanced analytical applications in both basic research and industrial contexts. The Life Science and Equipment Development segment focuses on automatic cell culture devices and other automation equipment, serving medical, biotechnology, and research sectors. These devices are developed and sold for use in laboratories and research institutions. The company also provides outsourced manufacturing and proprietary products to research institutes and businesses across various industries. JTEC Corp's website is www.j-tec.co.jp, offering further information about its products and services. The company maintains a presence in the health care industry, leveraging automation technology to support scientific research and medical advancements. Its operations reflect a niche focus on precision engineering for specialized applications in high-tech research environments. JTEC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JTEC stock

EBIT Margin (Operating Margin) of JTEC is 3.73 % in 2026.

EBIT Margin (Operating Margin) of JTEC changed from 5.91 % to 3.73 %, representing a -36.97% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) JTEC since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s JTEC with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — JTEC

All Key Metrics — JTEC